Fibrinolytic and coagulation systems in the blood vessels in stroke-prone SHR (SHRSP) [proceedings]. 1979

Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001158 Arteries The vessels carrying blood away from the heart. Artery
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
September 1979, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
September 1979, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
September 1979, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
September 1979, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
September 1979, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
July 1978, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
January 1991, Clinical and experimental hypertension. Part A, Theory and practice,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
September 1979, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
May 1976, Japanese heart journal,
Y Yamori, and K Ohta, and R Horie, and Y Nara, and M Ohtaka, and A Ooshima
January 1981, International journal of biological research in pregnancy,
Copied contents to your clipboard!